WO1994021612A1 (en)* | 1993-03-18 | 1994-09-29 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives as matrix metalloproteinases inhibitors |
US5594006A (en)* | 1993-03-18 | 1997-01-14 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives as matrix metalloproteinases inhibitors |
EP0740652B1 (en)* | 1994-01-20 | 1998-05-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
GB9423914D0 (en)* | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5639746A (en)* | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5919940A (en)* | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
US5672598A (en)* | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
US5917090A (en)* | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
US6127427A (en) | 1995-11-23 | 2000-10-03 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
ATE272062T1 (en)* | 1996-08-28 | 2004-08-15 | Procter & Gamble | SPIROCYCLIC METALLOPROTEASE INHIBITORS |
EP0927168B1 (en)* | 1996-08-28 | 2002-11-06 | The Procter & Gamble Company | 1,3-diheterocyclic metalloprotease inhibitors |
CA2263917A1 (en)* | 1996-08-28 | 1998-03-05 | Kelly Lynn Mcdow-Dunham | Heterocyclic metalloprotease inhibitors |
CZ63699A3 (en)* | 1996-08-28 | 1999-07-14 | The Procter & Gamble Company | Compounds based on amides of phosphinic acid as inhibitors of intercellular matter metalloproteases, process of their preparation and their use as medicaments |
HUP0000505A3 (en)* | 1996-08-28 | 2001-12-28 | Procter & Gamble | Saturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
ATE220660T1 (en) | 1996-09-10 | 2002-08-15 | British Biotech Pharm | CYTOSTATIC HYDROXAMIC ACID DERIVATIVES |
IL134273A0 (en) | 1997-07-31 | 2001-04-30 | Procter & Gamble | Acyclic metalloprotease inhibitors |
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
AU778005B2 (en) | 1998-12-24 | 2004-11-11 | Bristol-Myers Squibb Pharma Company | Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
US6566381B1 (en) | 1999-03-03 | 2003-05-20 | The Procter & Gamble Company | Hetero-substituted metalloprotease inhibitors |
RU2001126721A (en) | 1999-03-03 | 2004-02-20 | Дзе Проктер Энд Гэмбл Компани (US) | Alkenyl and alkynyl-containing metal prosthetics inhibitors |
US6696456B1 (en) | 1999-10-14 | 2004-02-24 | The Procter & Gamble Company | Beta disubstituted metalloprotease inhibitors |
WO2001060826A2 (en) | 2000-02-17 | 2001-08-23 | Bristol-Myers Squibb Pharma Company | SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
EP1265865A2 (en) | 2000-03-21 | 2002-12-18 | The Procter & Gamble Company | Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
IL151125A0 (en) | 2000-03-21 | 2003-04-10 | Procter & Gamble | Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
US6495540B2 (en) | 2000-03-28 | 2002-12-17 | Bristol - Myers Squibb Pharma Company | Lactams as inhibitors of A-β protein production |
EP1268434A1 (en) | 2000-04-03 | 2003-01-02 | Bristol-Myers Squibb Pharma Company | Cyclic lactams as inhibitors of a-beta protein production |
JP2003535046A (en) | 2000-04-03 | 2003-11-25 | デュポン ファーマシューティカルズ カンパニー | Cyclic lactams as inhibitors of Aβ protein production |
IL147629A0 (en) | 2000-06-01 | 2002-08-14 | Bristol Myers Squibb Pharma Co | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |